Intrinsic Value of S&P & Nasdaq Contact Us

CytomX Therapeutics, Inc. CTMX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
69/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.60
+155.5%

CytomX Therapeutics, Inc. (CTMX) has 7 identified peers for comparison in the Healthcare sector. Peers include ACHL, ASMB, NLTX, NUVB, NXTC, SPRO and others.

CTMX has a market capitalization of $772.94M, compared to an average peer market cap of $352.77M. CTMX is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message